These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 8114691)
1. Suppression of albumin enhancer activity by H-ras and AP-1 in hepatocyte cell lines. Hu J; Isom HC Mol Cell Biol; 1994 Mar; 14(3):1531-43. PubMed ID: 8114691 [TBL] [Abstract][Full Text] [Related]
2. Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes. Isom HC; Woodworth CD; Meng Y; Kreider J; Miller T; Mengel L Cancer Res; 1992 Feb; 52(4):940-8. PubMed ID: 1371091 [TBL] [Abstract][Full Text] [Related]
3. Site-directed mutagenesis of hepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region. Costa RH; Grayson DR Nucleic Acids Res; 1991 Aug; 19(15):4139-45. PubMed ID: 1870969 [TBL] [Abstract][Full Text] [Related]
5. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Nerlov C; Rørth P; Blasi F; Johnsen M Oncogene; 1991 Sep; 6(9):1583-92. PubMed ID: 1923525 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of a conserved sequence element by ras requires a nuclear factor distinct from c-fos or c-jun. Owen RD; Ostrowski MC Proc Natl Acad Sci U S A; 1990 May; 87(10):3866-70. PubMed ID: 2111019 [TBL] [Abstract][Full Text] [Related]
7. An enhancer element responsive to ras and fms signaling pathways is composed of two distinct nuclear factor binding sites. Reddy MA; Langer SJ; Colman MS; Ostrowski MC Mol Endocrinol; 1992 Jul; 6(7):1051-60. PubMed ID: 1324418 [TBL] [Abstract][Full Text] [Related]
8. ATBF1, a multiple-homeodomain zinc finger protein, selectively down-regulates AT-rich elements of the human alpha-fetoprotein gene. Yasuda H; Mizuno A; Tamaoki T; Morinaga T Mol Cell Biol; 1994 Feb; 14(2):1395-401. PubMed ID: 7507206 [TBL] [Abstract][Full Text] [Related]
9. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway. Yue J; Mulder KM J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986 [TBL] [Abstract][Full Text] [Related]
10. Interplay between a new HNF3 and the HNF1 transcriptional factors in the duck hepatitis B virus enhancer. Crescenzo-Chaigne B; Pillot J; Lilienbaum A Virology; 1995 Oct; 213(1):231-40. PubMed ID: 7483267 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of the human chromogranin A gene by its 5' distal regulatory element: novel effects of orientation, structure, flanking sequences, and position on expression. Nolan EM; Cheung TC; Burton DW; Deftos LJ Mol Cell Endocrinol; 1996 Nov; 124(1-2):51-62. PubMed ID: 9027324 [TBL] [Abstract][Full Text] [Related]
12. Regulation of alpha-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site. Zhang XK; Dong JM; Chiu JF J Biol Chem; 1991 May; 266(13):8248-54. PubMed ID: 1708774 [TBL] [Abstract][Full Text] [Related]
13. fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element. McBride K; Robitaille L; Tremblay S; Argentin S; Nemer M Mol Cell Biol; 1993 Jan; 13(1):600-12. PubMed ID: 8417355 [TBL] [Abstract][Full Text] [Related]
14. Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations. Liu C; Mason WS; Burch JB J Virol; 1994 Apr; 68(4):2286-96. PubMed ID: 8139013 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the AP-1 sites in the IL-2 promoter. Jain J; Valge-Archer VE; Rao A J Immunol; 1992 Feb; 148(4):1240-50. PubMed ID: 1737937 [TBL] [Abstract][Full Text] [Related]
16. Identification of a GABP alpha/beta binding site involved in the induction of oxytocin receptor gene expression in human breast cells, potentiation by c-Fos/c-Jun. Hoare S; Copland JA; Wood TG; Jeng YJ; Izban MG; Soloff MS Endocrinology; 1999 May; 140(5):2268-79. PubMed ID: 10218980 [TBL] [Abstract][Full Text] [Related]
17. Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro. Liu JK; DiPersio CM; Zaret KS Mol Cell Biol; 1991 Feb; 11(2):773-84. PubMed ID: 1990282 [TBL] [Abstract][Full Text] [Related]
18. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors. Bailly A; Torres-Padilla ME; Tinel AP; Weiss MC Nucleic Acids Res; 2001 Sep; 29(17):3495-505. PubMed ID: 11522818 [TBL] [Abstract][Full Text] [Related]
19. Identification of a decidua-specific enhancer on the human prolactin gene with two critical activator protein 1 (AP-1) binding sites. Watanabe K; Kessler CA; Bachurski CJ; Kanda Y; Richardson BD; Stanek J; Handwerger S; Brar AK Mol Endocrinol; 2001 Apr; 15(4):638-53. PubMed ID: 11266514 [TBL] [Abstract][Full Text] [Related]
20. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]